Philippine Dermatological Society   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Quezon City Philippines (1952)

Organization Overview

First Clinical Trial
2013
NCT01783353
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Philippine Dermatological Society

Active Ingredients

Drugs in Phase 3 Trials (1)

zinc gluconate (1 trial)

Drugs in Phase 2 Trials (5)

atorvastatin (lipitor) (1 trial)

clofazimine (lamprene) (1 trial)

coconut oil (1 trial)

dapsone (aczone) (1 trial)

rifampin (1 trial)

Drugs in Phase 1 Trials (2)

mupirocin (bactroban) (1 trial)

papaya (1 trial)

Drugs in Other Trials (1)

senna alexandrina (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Impetigo (Phase 1)

Leprosy (Phase 2)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 9